logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Human Genome Sciences, Inc.


USPTO Granted Patents = 676

% Expired Patents = 33.6



Trademarks = 4

Forward Citations = 7,885

Loading Chart...
Loading Chart...

226 inventors (with patents filed for the assignee):

goldMedal Craig A Rosen (312 out of 329 patents)

silverMedal Steven M Ruben (254 out of 266 patents)

bronzeMedal Jian Ni (180 out of 190 patents)

4.  Guo-Liang Yu (101 out of 142 patents)

5.  Reiner L Gentz (80 out of 82 patents)

6.  Mark D Adams (72 out of 84 patents)

7.  Henrik S Olsen (59 out of 61 patents)

8.  Haodong Li (56 out of 60 patents)

9.  Reinhard Ebner (54 out of 55 patents)

10.  Ying-Fei Wei (53 out of 56 patents)

11.  Reiner L Gentz (53 out of 59 patents)

12.  Yi Li (52 out of 62 patents)

13.  Patrick J Dillon (52 out of 62 patents)

14.  Daniel R Soppet (39 out of 40 patents)

15.  Paul A Moore (38 out of 81 patents)


Core Competencies:
Albumin Fusion Proteins
Vascular Endothelial Growth Factor
B Lymphocyte Stimulator
Antibodies
Tumor Necrosis Factor
Sialylation Pathways
Neutrokine-alpha
Cytokine Receptors
Immunoglobulin Production
Polypeptides
Human MutY
Medical Injector

676 patents:

1. 9403905 - Vascular endothelial growth factor 2 (2016-08-02),
2. 9296809 - Albumin fusion proteins (2016-03-29),
3. 9221896 - Albumin fusion proteins (2015-12-29),
4. 9187548 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein (2015-11-17),
5. 9168286 - Methods and compositions for use in treatment of patients with autoantibody positive disease (2015-10-27),
6. 8993517 - Albumin fusion proteins (2015-03-31),
7. 8969538 - Albumin fusion proteins (2015-03-03),
8. 8946156 - Albumin Fusion Proteins (2015-02-03),
9. 8937169 - Human G-protein chemokine receptor HSATU68 (2015-01-20),
10. 8784809 - Vascular endothelial growth factor 2 (2014-07-22),
11. 8546105 - Engineering intracellular sialylation pathways (2013-10-01),
12. 8518389 - Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides (2013-08-27),
13. 8513189 - Albumin fusion proteins (2013-08-20),
14. 8410248 - HWBAO62 polypeptides (2013-04-02),
15. 8372948 - 12 human secreted proteins (2013-02-12),
Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company that specializes in the discovery and development of novel drugs to treat various diseases. HGS is committed to improving patients' lives by advancing the understanding and treatment of human genetics. With a focus on genomics research, they strive to discover innovative therapies for conditions such as cancer, infectious diseases, and autoimmune disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Human Genome Sciences, Inc.
676 Patents

#1 in Rockville, MD

#9 in Maryland

#739 in US

#1,469 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Human Genome Sciences, Inc.

Forward Citations = 7,885

226 inventors:

goldMedal Craig A Rosen (312 out of 329 patents)

silverMedal Steven M Ruben (254 out of 266 patents)

bronzeMedal Jian Ni (180 out of 190 patents)

4.  Guo-Liang Yu (101 out of 142 patents)

5.  Reiner L Gentz (80 out of 82 patents)

Please report any incorrect information to [email protected]
Loading…